OPAT as billing work
Outpatient parenteral antimicrobial therapy creates a chain of site-of-service, supply and visit claims. ROOT tracks the administrative sequence and the owner of each packet. We do not design the regimen.
Specialty focus
Infectious Disease Revenue Operations — From Authorization to Reimbursement
Authorization, infusion and OPAT billing pathways, J-code unit hygiene, and medical versus pharmacy benefit routing — as administrative revenue operations for ID groups.
This is not clinical care, stewardship advice or a treatment protocol. ROOT does not diagnose, prescribe or manage patients.
- OPAT coordination as billing work
- Infusion buy-and-bill vs specialty pharmacy
- Medical vs pharmacy benefit routing
Infusion: buy-and-bill vs specialty pharmacy
The same infusion can travel as a medical-benefit buy-and-bill claim or as a pharmacy-benefit specialty fill. The operations problem is routing, units and who bills. Product choice stays with the practice.
J-code unit hygiene
Drug-unit claims fail on wastage documentation, calendar alignment and unit math. ROOT reviews the current code set with your billing lead rather than relying on a static list.
Authorization sequencing
ID schedules stall when authorization, start of care and the first billed unit are out of order. ROOT names the next administrative action. Coverage decisions remain with the plan.
Medical vs pharmacy benefit
Benefit routing is an enrollment and claims problem: which side of the plan the drug falls on, and which portal the packet uses. It is not a clinical substitution decision.
Code-level guidance is reviewed with your billing lead during onboarding, because code sets change every year.